(PharmaNewsWire.Com, March 15, 2017 ) Global market for Cardiovascular Diagnostic and Monitoring Devices was worth $1754 million in 2016 and estimated to be growing at a CAGR of 6.4%, to reach $2391.87 million by 2021. Cardiovascular disease is a medical condition which affects the structure and function of organs associated with function of heart and its circulation
Cardio Vascular diseases are the primary cause of death and witnessing a high rise in prevalence. There are a large number of people being diagnosed with cardiovascular diseases such as periphery artery diseases, coronary artery diseases, congenital heart diseases, and pulmonary conditions shifting focus towards preventative healthcare.
Increasing risks related to hypertension, heart muscle weakening, increasing number of people suffering from diabetes and obesity are the major factors driving the market. Technological advancements have enabled additional features such as portability in performing various tests which are further adding to the growth of Cardiovascular Monitoring market. However unclear reimbursement policies, strict government regulations for products and high cost of monitoring devices are some the major factors hindering the growth of the market
Global market for cardiovascular diagnostic and monitoring devices is analysed on the basis of product which is further segmented into ECG systems, Holter Monitors, Event Monitors, Implantable loop recorders and ECG management systems. Electrocardiographs segment is further sub segmented into Resting ECG systems and Stress ECG systems. ECG systems accounted for the largest share in the market and expected to maintain its strong hold in the market during the forecast period due to widespread availability and increasing preference for these devices in both developed and developing regions.
On the basis of geography global market for cardiovascular diagnostic and monitoring devices market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America is the largest market for cardiovascular diagnostic and monitoring devices market and is expected to sustain its strong share owing to its favourable reimbursement policies and high awareness about available diagnosis and treatment methods among patients and physicians. Asia-Pacific is estimated to be the fastest growing region during the forecast period due to rising awareness about the effectiveness of accessible devices in successfully curing several cardio vascular conditions and increasing healthcare spending.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
